Prognostic relevance of nutritional status in patients with advanced esophageal cancer

Expert Review of Anticancer Therapy

Volumn 13, Issue 3, 2013, Pages 275-278

  Bollschweiler, Elfriede ^a   Herbold, Till ^a   Plum, Patrick ^a   Hölscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

adenocarcinoma; chemoradiation; esophageal cancer; multimodal therapy; nutrition; squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; INCIDENCE; MALNUTRITION; NUTRITIONAL STATUS; OBESITY; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; SMOKING; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADENOCARCINOMA; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOADJUVANT THERAPY; NUTRITIONAL STATUS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84874863827     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.12.176     Document Type: Article

References (19)

1. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann. Oncol. 23(12), 3155-3162 (2012).
2. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92(3), 549-555 (2001).
3. O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut 61(9), 1261-1268 (2012).
4. Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut 61(10), 1390-1397 (2012).
5. Bollschweiler E, Wolfgarten E, Nowroth T, Rosendahl U, Mönig SP, Hölscher AH. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J. Cancer Res. Clin. Oncol. 128(10), 575-580 (2002).
6. Lahmann PH, Pandeya N, Webb PM, Green AC, Whiteman DC; Australian Cancer Study. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer 118(7), 1901-1909 (2012).
7. Ramos Chaves M, Boléo-Tomé C, Monteiro-Grillo I, Camilo M, Ravasco P. The diversity of nutritional status in cancer: new insights. Oncologist 15(5), 523-530 (2010).
8. Grotenhuis BA, Wijnhoven BP, Hötte GJ, van der Stok EP, Tilanus HW, van Lanschot JJ. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J. Surg. 34(11), 2621-2627 (2010).
9. Melis M, Weber JM, McLoughlin JM et al. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann. Surg. Oncol. 18(3), 824-831 (2011).
10. Hayashi Y, Correa AM, Hofstetter WL et al. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24), 5619-5627 (2010).
11. Yoon HH, Lewis MA, Shi Q et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J. Clin. Oncol. 29(34), 4561-4567 (2011).
12. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur. J. Cancer 34(4), 503-509 (1998).
13. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12(Suppl. 1), S15-S19 (1996).
14. Shridhar R, Hayman T, Hoffe SE et al. Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy. J. Gastrointest. Surg. 16(7), 1296-1302 (2012).
15. Mariette C, De Botton ML, Piessen G. Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice? Ann. Surg. Oncol. 19(7), 2128-2134 (2012).
16. Clavier JB, Antoni D, Atlani D et al. Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis. Esophagus doi:10.1111/j.1442-2050.2012.01441.x (2012) (Epub ahead of print).
17. Sjoquist KM, Burmeister BH, Smithers BM et al.; Australasian Gastro-Intestinal Trials Group. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 12(7), 681-692 (2011).
18. Hölscher AH, Bollschweiler E. Choosing the best treatment for esophageal cancer: criteria for selecting the best multimodal therapy. Recent Results Cancer Res. 196, 169-177 (2012).
19. Semrau R, Herzog SL, Vallböhmer D, Kocher M, Hölscher AH, Müller RP. Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer. Dis. Esophagus 25(6), 545-554 (2012).